{"id":482270,"title":"Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T18:44:25.747000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/inhalers/release-final-guidance-document-data-requirements-safety-effectiveness-subsequent-market-entry-steroid-nasal-products-use-treatment-allergic-rhinitis.html?wbdisable=true","snippet":"Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry (PDF Version - 118 K) Contact: Bureau of Cardiology, Allergy and Neurological Sciences (BCANS) September 19, 2011 Notice Our…","rawSnapshotUrl":"/api/snapshots/raw/482270","browseUrl":"https://replay.healtharchive.ca/job-6/20260106184425/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/inhalers/release-final-guidance-document-data-requirements-safety-effectiveness-subsequent-market-entry-steroid-nasal-products-use-treatment-allergic-rhinitis.html?wbdisable=true#ha_snapshot=482270","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}